New! Sign up for our free email newsletter.
Science News
from research organizations

New opportunities for personalized cancer medicine

Date:
April 5, 2011
Source:
Technical Research Centre of Finland (VTT)
Summary:
Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many cancers. However, the precise molecular composition of lipids in tumors remains generally poorly characterized. Scientists have now found lipids in tumors which are associated with cancer progression.
Share:
FULL STORY

Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many cancers. However, the precise molecular composition of lipids in tumours remains generally poorly characterised. Scientists from VTT Technical Research Centre of Finland and the Charité Hospital have found lipids in tumours which are associated with cancer progression.

A new study performed by Matej Orešič and colleagues from the VTT Technical Research Centre of Finland in collaboration with the team of Carsten Denkert (Institute of Pathology, Charité Hospital, Berlin, Germany) in the European consortium METAcancer reveals specific lipids found in tumours associated with cancer progression and patient survival. These findings, which were published in Cancer Research, might be an important step towards the development of personalised cancer therapeutics.

The team used lipidomics, a high-throughput method for detecting molecular lipids, to analyse a large number of breast tumour tissues. Specific phospholipids related to cellular fatty acid synthesis were associated with cancer progression and patient survival. Follow-up in vitro studies, including gene silencing, identified several lipid metabolism genes behind the observed lipid changes in tumours.

The findings imply that phospholipids may have diagnostic potential, and that modulation of their metabolism may provide new therapeutic opportunities in breast cancer treatment.

The research leading to these results has received funding from the European Commission's 7th RTD Framework Programme (Collaborative Project no. HEALTH-F2-2008-200327).


Story Source:

Materials provided by Technical Research Centre of Finland (VTT). Note: Content may be edited for style and length.


Journal Reference:

  1. M. Hilvo, C. Denkert, L. Lehtinen, B. Muller, S. Brockmoller, T. Seppanen-Laakso, J. Budczies, E. Bucher, L. Yetukuri, S. Castillo, E. Berg, H. Nygren, M. Sysi-Aho, J. L. Griffin, O. Fiehn, S. Loibl, C. Richter-Ehrenstein, C. Radke, T. Hyotylainen, O. Kallioniemi, K. Iljin, M. Oresic. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Research, 2011; DOI: 10.1158/0008-5472.CAN-10-3894

Cite This Page:

Technical Research Centre of Finland (VTT). "New opportunities for personalized cancer medicine." ScienceDaily. ScienceDaily, 5 April 2011. <www.sciencedaily.com/releases/2011/04/110405084244.htm>.
Technical Research Centre of Finland (VTT). (2011, April 5). New opportunities for personalized cancer medicine. ScienceDaily. Retrieved March 29, 2024 from www.sciencedaily.com/releases/2011/04/110405084244.htm
Technical Research Centre of Finland (VTT). "New opportunities for personalized cancer medicine." ScienceDaily. www.sciencedaily.com/releases/2011/04/110405084244.htm (accessed March 29, 2024).

Explore More

from ScienceDaily

RELATED STORIES